Skip to navigation Skip to content

Barancik Prize for Innovation in MS Research


In this article


The Barancik Prize for Innovation in Multiple Sclerosis Research recognizes an exceptional scientist or a team of scientists whose work in MS research has demonstrated outstanding innovation and originality. This annual prize, made possible by the generosity of the Charles and Margery Barancik Foundation, is $100,000 to be used at the discretion of the recipient.

Read about the 2016 recipient – Daniel Reich, MD, PhD
Read about the 2015 recipients –  Laura Balcer, MD, MSCE, Peter Calabresi, MD, and Elliot Frohman, MD, PhD, FAAN, FANA
Read about the 2014 recipient – Philip De Jager, MD, PhD
Read about the 2013 recipient – Jonah Chan, PhD

Criteria and nominations

The goal of the prize is to recognize innovation in scientific research in the field of multiple sclerosis. Nominations must be submitted on behalf an individual, or team of individuals, by one or more colleagues or mentors. Self-nominations are not permitted. Nomination letters should include current institution and contact information of the nominator and nominee. The narrative should address the nominee’s scientific accomplishments with an emphasis on citing the innovative and impactful aspects of the nominee’s work, including a maximum of 2 journal citations if appropriate.

Previous nominations are not automatically carried forward. If you wish to re-nominate a previous candidate, please update the earlier nomination with any significant developments and/or citations and resubmit.

A selection committee comprised of leaders in science, medicine, and MS advocacy will review nominees. The committee will evaluate:

• Exceptional innovation and originality in scientific research relevant to MS
• Impact and potential of the research to lead to pathways for the treatment and cure for MS
• Scientific accomplishments that merit recognition as a future leader in MS research

Nominees that exhibit these qualities will be invited to submit a final application that will include an interview by the selection committee.


Any investigator(s) active in MS research is eligible for the prize, and the nominee(s) may be from any institution or organization— public or private, government, as well as commercial entities. The award is intended for early to mid-career MS researchers. Nominees should have no more than 20 years of experience as an independent investigator or team leader to be eligible. There are no specific requirements for residency or citizenship. Nominees need not be current or past grantees of the National MS Society.


Nomination letters should be sent to starting November 16, 2016 until the January 31, 2017 deadline to be considered for the 2017 prize. Notification of the recipient shall occur by June 2017 followed by a public announcement.

About the Charles and Margery Barancik Foundation

For over twenty years, Charles and Margery Barancik have been major supporters of research projects in the field of multiple sclerosis. The Charles and Margery Barancik Foundation was organized to carry out some of the Barancik Family’s philanthropic programs. They recognize and believe in the power and influence that one creative and driven individual can have on the course of future events. The Barancik family members have noted the impressive achievements of singular individuals in driving change and attracting others to a cause. Their goal in establishing the Barancik Prize is to recognize and reward MS scientists who can positively and imaginatively impact the direction of MS research going forward. The Foundation is administered through the auspices of the Gulf Coast Community Foundation (GCCF). The Foundation will only consider proposals that it has specifically requested; unsolicited requests will not be considered.